CoRISMA Raises $27M in Series A Funding

01 Sep, 2021

CoRISMA Raises $27M in Series A Funding
Photo by Craig Cooper on Unsplash

– CoRISMA, a New Haven CT-based stage medical device company, raised $27M in Series A funding.
– The round was led by China Grand Pharmaceutical and Healthcare Holdings Limited.
– The company intends to use the funds to accelerate development and expand availability of the CoRISMA cardiac treatment device.

Life Science North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: